Derivative Liabilities (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 12, 2021 |
Nov. 06, 2020 |
Jul. 29, 2021 |
Feb. 23, 2021 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Aug. 09, 2023 |
Aug. 31, 2021 |
|
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | $ 433,600 | |||||||||||
| SPAC warrants | $ 3,762 | 137,698 | ||||||||||
| Warrant, description | Each Public SPAC Warrant entitles the holder to purchase one-fortieth of one share of the Company’s common stock at an exercise price of $5.75 per 1/40th of one share, or $230.00 per whole share, subject to adjustment. | |||||||||||
| Beneficial ownership | 4.99% | |||||||||||
| Outstanding warrants, Percentage | 10.00% | |||||||||||
| Warrant purchase share (in Shares) | 1,250 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 141.4 | $ 141.4 | ||||||||||
| Business combination warrants value | $ 0 | |||||||||||
| Fair value of derivative liabilities | 6,474,200 | |||||||||||
| Warrant revalued | 400 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 100 | $ 1.78 | $ 150 | |||||||||
| Fair value of warrants | $ 43,561 | |||||||||||
| Private Placement [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Aggregate amount (in Shares) | 502,500 | 502,500 | ||||||||||
| Warrant revalued amount | $ 0 | 20,100 | ||||||||||
| SPAC warrants | 10,050 | 447,225 | $ 467,325 | |||||||||
| Warrant, description | Each Private SPAC Warrant entitles the holder to purchase one-fortieth of one share of the Company’s common stock at an exercise price of $5.75 per 1/40th of one share, or $230.00 per whole share, subject to adjustment. | Each Private Warrant entitles the holder to purchase one-fortieth of one share of the Company’s common stock at an exercise price of $5.75 per 1/40th of one share, or $230.00 per whole share, subject to adjustment. No fractional shares will be issued upon exercise of the warrants. The Private Warrants are currently exercisable and will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. The Private Warrants are non-redeemable so long as they are held by original holders or their permitted transferees. If the Private Warrants are held by other parties, the Company may redeem the Private Warrants, in whole and not in part, at a price of $0.01 per Warrant upon 30 days’ notice (“30-day redemption period”), only in the event that the last sale price of the common stock equals or exceeds $360.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given, provided there is an effective registration statement with respect to the shares of common stock underlying such Warrants and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period. | ||||||||||
| Business combination warrants value | $ 587,925 | |||||||||||
| Fair value of derivative liabilities | 466,069 | $ 211,050 | ||||||||||
| Fair value of derivative liabilities | 1,256 | |||||||||||
| Fair value of warrants | 52,116 | |||||||||||
| Private Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Business combination warrants value | 43,561 | |||||||||||
| Public SPAC Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | 592,250 | |||||||||||
| SPAC warrants | $ 31,625 | 8,048,850 | ||||||||||
| Warrant, description | Each Public SPAC Warrant entitles the holder to purchase one-fortieth of one share of the Company’s common stock at an exercise price of $5.75 per 1/40th of one share, or $230.00 per whole share, subject to adjustment. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants are currently exercisable and will expire on November 6, 2025, or earlier upon redemption or liquidation. The Company may redeem the Public Warrants, in whole and not in part, at a price of $0.01 per Public Warrant upon 30 days’ notice (“30-day redemption period”), only in the event that the last sale price of the common stock equals or exceeds $360.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given, provided there is an effective registration statement with respect to the shares of common stock underlying such Public Warrants and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period. | |||||||||||
| Business combination warrants value | $ 1,978,000 | |||||||||||
| Fair value of derivative liabilities | $ 8,017,225 | 4,253,850 | ||||||||||
| Public SPAC Warrants [Member] | IPO [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Aggregate amount (in Shares) | 11,500,000 | 11,500,000 | ||||||||||
| PIPE Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Purchase of shares of common stock (in Shares) | 128,200 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 100 | |||||||||||
| Fair value of derivative liabilities | 778,536 | |||||||||||
| Fair value of PIPE warrants | $ 7,294,836 | |||||||||||
| Warrant revalued | $ 42,100 | 6,516,300 | ||||||||||
| Alpha Warrant [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Purchase of aggregate shares (in Shares) | 1,250 | |||||||||||
| Beneficial ownership | 4.99% | |||||||||||
| Fair value of PIPE warrants | $ 95,677 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 141.4 | |||||||||||
| AGP Warrant [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Purchase of aggregate shares (in Shares) | 3,183 | 3,183 | ||||||||||
| Exercise price per share (in Dollars per share) | $ 105.6 | |||||||||||
| Fair value of derivative liabilities | $ 143,931 | 21,564 | ||||||||||
| Warrant revalued | $ 144,331 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 105.6 | |||||||||||
| Public SPAC Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | $ 5,405 | |||||||||||
| SPAC warrants | $ 230 | 1,246,600 | 26,220 | 7,456,600 | ||||||||
| Private Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| SPAC warrants | 0 | 1,256 | ||||||||||
| PIPE Warrants [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | 200 | |||||||||||
| SPAC warrants | 1,800 | 188,000 | 41,900 | 6,082,700 | ||||||||
| Purchase of shares of common stock (in Shares) | 128,200 | |||||||||||
| Warrant, Exercise Price, Increase (in Dollars per share) | $ 100 | |||||||||||
| AGP Warrant [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | 6,633 | |||||||||||
| SPAC warrants | 6 | 400 | ||||||||||
| Purchase of aggregate shares (in Shares) | 3,183 | |||||||||||
| Exercise price per share (in Dollars per share) | $ 105.6 | |||||||||||
| Warrants Revalued amount | 0 | $ 0 | ||||||||||
| Alpha Warrant [Member] | ||||||||||||
| Derivative Liabilities (Details) [Line Items] | ||||||||||||
| Warrant revalued amount | 224 | |||||||||||
| SPAC warrants | $ 1,496 | $ 43,337 | ||||||||||
| Beneficial ownership | 4.99% | |||||||||||
| Revalued warrant | $ 0 | $ 0 | ||||||||||